Healthtech Startups

Resonant Technologies Group is a company creator and accelerator that builds and operates ventures based on "Resonance Physics," spanning health diagnostics, frequency-based wellness products, immunotherapy, agriculture, audio hardware, and mineral extraction. Its operating companies include Sonaphi, Field Futures, Sourcewave, Divina Biotech, UpTerra, Form Audio, and Manna Vitality, focused on human health, energy, and the environment.

2 investors

Resonant develops antibody-based therapeutics for oncology using deep cancer biology and drug discovery expertise. The company leverages world-class antibody engineering capabilities to advance oncology drug programs.

2 investors

Respiosa develops a minimally invasive surgical implant to treat obstructive sleep apnea by preventing tongue collapse during sleep, targeting patients for whom current treatments like CPAP are ineffective or poorly tolerated.

2 investors

Respira develops inhaled therapeutic products for pulmonary diseases, including a novel dry-powder inhalation device and lead product candidate RT234 for pulmonary arterial hypertension. The company focuses on creating drug-device combination products using advanced particle engineering and formulation technologies.

2 investors

Restorative Neurotechnologies develops digital therapies certified as medical devices (MindLenses Professional) for cognitive rehabilitation in neurological conditions and neurodevelopmental disorders such as post-stroke recovery and ADHD, used in public and private healthcare facilities. It also offers MindPAth, a consumer-oriented cognitive training product, with a market focus in Italy and Europe.

2 investors

Restore Medical is a medical device company in the cardiology field, developing technology associated with interventional cardiology and cardiac research.

2 investors

RestorixHealth develops and operates wound care centers in partnership with hospitals, delivers professional wound care services in nursing facilities and home settings, and coordinates wound care supplies to improve patient access and outcomes.

2 investors

Rev Genomics uses genomic selection, tissue culture, and molecular analysis to develop high-value crop cultivars for breeders and seed banks. The company creates novel plant phenotypes and provides molecular fingerprinting and breeding technology primarily for specialty crops in California.

2 investors

RevMed is an advanced regenerative medicine company focused on researching and developing therapeutic solutions in the regenerative medicine field. The company aims to extend human lifespan and improve health outcomes through life-centered innovation.

2 investors

Reveal Health Tech builds AI-powered software for healthcare using human-centered, trustworthy artificial intelligence. The company serves healthcare organizations and clinicians seeking to incorporate AI into their operations.

2 investors

Revecore provides AI-driven revenue cycle management and revenue integrity solutions for hospitals and health systems, recovering revenue from complex claims and reimbursement challenges that traditional workflows typically miss.

2 investors

Revella Health deploys clinical teams into communities to close HEDIS gaps and capture undocumented diagnoses for Medicare Advantage and ACA Marketplace health plans through face-to-face member visits that generate Star Rating and risk adjustment data.

2 investors

Revena provides an AI system for hospitals that reads commercial contracts and clinical records (medical progress notes, prescriptions, exams, surgical descriptions) to automatically assemble justified, contract-compliant medical bills and post validated items into hospital information systems (HIS). It targets hospital revenue and billing operations in Brazil.

2 investors

ReviMo develops Niko, a mobility assistance device that helps individuals with limited mobility transfer, move, and elevate to a standing level, reducing dependence on caregivers. The device targets patients with limited mobility and their caregivers, and is subject to FDA approval.

2 investors

Revinova provides a learning platform and AI agent embedded in clinical trial management systems (CTMS) to train sites for clinical trials and reduce protocol deviations. The platform transforms study documents into role-based training and offers real-time guidance to trial coordinators, investigators, and data managers within their existing CTMS workflows.

2 investors

Revisto offers an AI-driven platform that automates compliance review and approval of promotional and marketing materials for pharmaceutical companies, learning from regulations, industry best practices, and customer history. It aims to reduce review cycle time and support the creation of compliant, personalized content, and counts a Top 5 pharmaceutical company among its customers.

2 investors

RreviveMed applies artificial intelligence to metabolomics and biology to support drug discovery in the pharmaceutical and biotech sector.

2 investors

Reviving Mind provides a healthcare platform that connects individuals with healthcare professionals and leverages collaborative care models for mental health and wellness. The company serves patients seeking well-being support across various mental health and sleep disorders.

2 investors

RevMedica develops smart surgical stapling and soft tissue management systems for minimally invasive and robotic procedures, designed to provide real-time intraoperative data and improve clinical decision-making for surgeons. The platform aims to enhance patient safety and reduce operating room waste while maintaining environmental sustainability.

2 investors

Revolve develops a surgical robotics platform with 5mm wristed instruments and zero-footprint design for operating rooms, enabling digital surgery at costs comparable to laparoscopy. The system is designed for access across independent outpatient centers and large health networks.

2 investors

Revuud operates an online marketplace that connects healthcare systems directly with skilled IT talent, allowing them to engage without a third-party staffing intermediary. It serves the healthcare industry in the United States.

2 investors

Rey.id addresses inefficiencies in the healthcare industry through solutions targeting health service provision, fraud prevention, and chronic disease management. The company seeks to make healthcare more accessible and economically balanced for providers, payers, and insurance companies.

2 investors

Reyedar develops an AI-powered eye tracking system that detects biomarkers of neurological and visual health conditions such as glaucoma and Parkinson's disease through automated oculomotor testing. The company serves optometry centers, hospitals, clinics, and clinical research centers seeking rapid, non-invasive screening for neurovisual disorders.

2 investors

Rgenta develops orally available small molecule therapies that target RNA to address diseases previously considered undruggable, with programs in oncology (targeting proteins such as MYB in solid tumors and hematologic cancers) and central nervous system repeat expansion disorders like Huntington's disease. It operates in the RNA-targeted drug development space.

2 investors